CEND’s 9th Annual Symposium: A Recap

Wednesday, 19 April 2017 by

By: Allison Terbush, Coscoy Lab Photo credit: Katherine Chen, Vance Lab It is estimated that up to one-third of the global population is infected with Mycobacterium tuberculosis, the infectious agent of tuberculosis disease. Tuberculosis itself, and in combination with other complicating circumstances such as HIV infection, is among the leading causes of death world-wide. Despite this

Aduro CEO Stephen Isaacs talk about IVRI and the Alliance for Global Health and Science during the opening bell for Nasdaq Market in New York City on March 28. Video can be found here.

2017 CEND Research Fellowship: Thomas C. Alber Science & Engineering for Global Health The “Science & Engineering for Global Health” Fellowship provides $10,000 for PhD candidates and postdocs interested in conducting infectious disease-related research in the lab of a collaborator in a low-or middle-income country. Through the fellowship, awards of $5,000 will be made to

2017 CEND Research Fellowship: Irving H. Wiesenfeld, Kathleen L. Miller Graduate Fellowship The purpose of the Irving H. Wiesenfeld, Kathleen L. Miller Graduate Fellowship is to provide research support to UC Berkeley graduate students of high distinction involved in the study of emerging and neglected infectious diseases, including basic science, discovery of effective treatments, diagnostics,

The 7th Annual Bay Area Symposium on Viruses will be held on May 19th, 2017 at the Li Ka Shing Center, UC Berkeley. About the Network The Bay Area Virus Network ( represents a constellation of scientists, engineers, and clinician researchers in the San Francisco Bay Area who are working to understand, prevent, and control

CEND’s 9th Annual Symposium will be held on March 31, 2017 from 9AM-5PM in 245 Li Ka Shing Center. This year’s symposium is ”Deconstructing TB: Insights from Fundamental Research.” Emerging and neglected diseases are a group of debilitating and often deadly infections. As a group, these diseases are poorly understood and generally lack effective tools for prevention,

ESPM Wildlife Lunch, Friday 27, Jan, 12-1 pm, Mulford 103 Emerging Disease at the Human-Wildlife Interface in Africa: What Are We Missing? Kathleen A. Alexander, Professor– Virginia Tech, College of Natural Resources Department of Fisheries and Wildlife Conservation, Blacksburg, VA With the emergence of Severe Acute Respiratory Syndrome (SARS) and Ebola virus to Middle East

This coalition is gearing up for the fight against infectious disease. Here’s what they’re doing: “Over the next 5 years, the CEPI plans to bankroll the development of vaccines against three viral threats—Middle East respiratory syndrome (MERS)-coronavirus, Lassa, and Nipah—so that small outbreaks never get a chance to become raging epidemics. Formed last year without serious funding,

UC Berkeley pioneers immunotherapy

Thursday, 19 January 2017 by

UC Berkeley’s Immunotherapeutics and Vaccine Research Institute is changing the way we think about cancer and infectious diseases. It turns out that these two have a lot in common, and IVRI is utilizing discoveries in both fields to create strides in treatment. The current issue of the journal Science Immunology features Russell Vance, Daniel Portnoy, Michael Eichberg, and David

On January 26, 1:30-4pm, the Quantitative Biology Institute at UCSF and the UCB Center for Emerging and Neglected Diseases will co-host a workshop entitled “Mass Spectrometry Workshop for Biologists” at the Faculty Club, with a reception to follow from 4-5pm. This CEND – QBI workshop is in collaboration with the Gladstone Institutes, Sanford Burnham Prebys and Thermo Fisher Scientific.

TOP UA-36873340-1